Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.

Shiota, Masaki; Nagakawa, Shohei; Tsukahara, Shigehiro; Matsumoto, Takashi; Tanegashima, Tokiyoshi; Eto, Masatoshi

Shiota, Masaki; Nagakawa, Shohei; Tsukahara, Shigehiro; Matsumoto, Takashi; Tanegashima, Tokiyoshi; Eto, Masatoshi.

Affiliation

Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nagakawa S; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tsukahara S; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsumoto T; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tanegashima T; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Int J Urol ; 31(8): 945-947, 2024 Aug.

Article in En | MEDLINE | ID: mdl-38687032

Subject(s)

BCG Vaccine; Disease Progression; Urinary Bladder Neoplasms; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/genetics; Urinary Bladder Neoplasms/pathology; Humans; BCG Vaccine/administration & dosage; BCG Vaccine/therapeutic use; Administration, Intravesical; Male; Female; Aged; Neoplasm Invasiveness; Adjuvants, Immunologic/administration & dosage; Adjuvants, Immunologic/therapeutic use; Middle Aged; Non-Muscle Invasive Bladder Neoplasms

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / BCG Vaccine / Disease Progression Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Urol Year: 2024 Document type: Article

Fulltext

XML

PubMed Links

Search on Google